Cart
sales@molnova.com
M435-1279
CAS No. 1359431-16-5
M435-1279( —— )
Catalog No. M37630 CAS No. 1359431-16-5
M435-1279 is a UBE2T inhibitor that blocks UBE2T-mediated degradation of RACK1, thereby inhibiting the hyperactivation of the Wnt/β-catenin signaling pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 47 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 205 | In Stock |
|
| 50MG | 306 | In Stock |
|
| 100MG | 423 | In Stock |
|
| 200MG | 596 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameM435-1279
-
NoteResearch use only, not for human use.
-
Brief DescriptionM435-1279 is a UBE2T inhibitor that blocks UBE2T-mediated degradation of RACK1, thereby inhibiting the hyperactivation of the Wnt/β-catenin signaling pathway.
-
DescriptionM435-1279 is a UBE2T inhibitor. M435-1279 inhibits the Wnt/β-catenin signaling pathway hyperactivation through blocking UBE2T-mediated degradation of RACK1.
-
In VitroCell Viability Assay Cell Line:HGC27, AGS, and MKN45 cells Concentration:0, 2, 4, 8, 16, 31 μM Incubation Time:48?h Result:Inhibited the cell growth. Cell Viability Assay Cell Line:HGC27, AGS, and MKN45 cells Concentration:0, 4, 8, 12, 16, 20 μM Incubation Time:Result:Inhibited the cell viability with IC50s of 16.8, 11.88, 6.93, 7.76 μM in GES-1, HGC27, MKN45, AGS cells, respectively.
-
In VivoAnimal Model:BALB/C nude mice CDX model (MKN45 tumor size: 75–100?mm3) Dosage:5?mg/kg/day Administration:Intratumor injection for 18 days Result:Slowed the tumor growth.Induced higher RACK1 proteins expression, and lower Ki-67 and β-catenin proteins expression in intratumor tumors.
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetE1
-
RecptorE1/E2/E3 Enzyme
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1359431-16-5
-
Formula Weight419.47
-
Molecular FormulaC18H17N3O5S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (119.20 mM; Ultrasonic )
-
SMILESNS(=O)(=O)c1ccc(NC(=O)c2c(O)c3c4CCCCc4sc3[nH]c2=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yu Z, et al. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination. Oncogene. 2021 Feb;40(5):1027-1042. doi: 10.1038/s41388-020-01572-w. Epub 2020 Dec 15. Erratum in: Oncogene. 2021 Apr;40(14):2622-2623.?
molnova catalog
related products
-
NSC232003
NSC232003 is a highly potent and cell-permeable inhibitor of UHRF1.
-
COH000
COH000 (COH-000) is a highly selective, first-in-class, irreversible, allosteric, covalent inhibitor of SUMO-Activating Enzyme E1.
-
M435-1279
M435-1279 is a UBE2T inhibitor that blocks UBE2T-mediated degradation of RACK1, thereby inhibiting the hyperactivation of the Wnt/β-catenin signaling pathway.
